Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification - PubMed (original) (raw)
Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification
C T Fong et al. Proc Natl Acad Sci U S A. 1989 May.
Abstract
Partial monosomy of the short arm of chromosome 1 is the most consistent cytogenetic abnormality found in human neuroblastomas, but its overall frequency and significance are unclear. Using a panel of chromosome-1-specific DNA probes that identify restriction fragment length polymorphisms, we demonstrate that 13 of 47 human neuroblastomas (28%) have somatic loss of heterozygosity (LOH) at one or more loci on the distal short arm of chromosome 1. the chromosomal region that shows LOH most consistently is between 1p36.1 and 1p36.3; loss of a gene or genes in this region may be critical for the development or progression of neuroblastomas. The region of LOH in human neuroblastoma may resemble that described for pheochromocytoma, medullary thyroid carcinoma, and melanoma, which are also tumors of neural-crest origin. Although LOH for distal chromosome 1p can occur in early stages of neuroblastoma, the loss usually occurs in tumors of advanced clinical stages. LOH for the short arm of chromosome 1 correlates significantly with N-myc amplification, suggesting that these two genetic events are related. Indeed, these two lesions appear to characterize a genetically distinct subset of particularly aggressive neuroblastomas.
Similar articles
- Clinical significance of genetic rearrangements in human neuroblastomas.
Brodeur GM. Brodeur GM. Clin Chem. 1989 Jul;35(7 Suppl):B38-42. Clin Chem. 1989. PMID: 2568197 Review. - Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T, Sjöberg RM, Hedborg F, Kogner P. Martinsson T, et al. Cancer Res. 1995 Dec 1;55(23):5681-6. Cancer Res. 1995. PMID: 7585654 - Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
Fong CT, White PS, Peterson K, Sapienza C, Cavenee WK, Kern SE, Vogelstein B, Cantor AB, Look AT, Brodeur GM. Fong CT, et al. Cancer Res. 1992 Apr 1;52(7):1780-5. Cancer Res. 1992. PMID: 1551108 - Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
Caron H, van Sluis P, van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voûte PA, Westerveld A, Versteeg R. Caron H, et al. Nat Genet. 1993 Jun;4(2):187-90. doi: 10.1038/ng0693-187. Nat Genet. 1993. PMID: 8102298 - Molecular basis of clinical heterogeneity in neuroblastoma.
Brodeur GM, Nakagawara A. Brodeur GM, et al. Am J Pediatr Hematol Oncol. 1992 May;14(2):111-6. doi: 10.1097/00043426-199205000-00004. Am J Pediatr Hematol Oncol. 1992. PMID: 1356315 Review.
Cited by
- Expression of ret proto-oncogene in human neuroblastomas.
Nagao M, Ishizaka Y, Nakagawara A, Kohno K, Kuwano M, Tahira T, Itoh F, Ikeda I, Sugimura T. Nagao M, et al. Jpn J Cancer Res. 1990 Apr;81(4):309-12. doi: 10.1111/j.1349-7006.1990.tb02566.x. Jpn J Cancer Res. 1990. PMID: 1694838 Free PMC article. - 1p36.32 rearrangements and the role of PI-PLC η2 in nervous tumours.
Lo Vasco VR. Lo Vasco VR. J Neurooncol. 2011 Jul;103(3):409-16. doi: 10.1007/s11060-010-0422-3. Epub 2010 Sep 29. J Neurooncol. 2011. PMID: 20878447 - Aberrant expression of RAB1A in human tongue cancer.
Shimada K, Uzawa K, Kato M, Endo Y, Shiiba M, Bukawa H, Yokoe H, Seki N, Tanzawa H. Shimada K, et al. Br J Cancer. 2005 May 23;92(10):1915-21. doi: 10.1038/sj.bjc.6602594. Br J Cancer. 2005. PMID: 15870709 Free PMC article. - Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.
Garcia I, Mayol G, Rodríguez E, Suñol M, Gershon TR, Ríos J, Cheung NK, Kieran MW, George RE, Perez-Atayde AR, Casala C, Galván P, de Torres C, Mora J, Lavarino C. Garcia I, et al. Mol Cancer. 2010 Oct 15;9:277. doi: 10.1186/1476-4598-9-277. Mol Cancer. 2010. PMID: 20950435 Free PMC article. - Identification of the genetic and clinical characteristics of neuroblastomas using genome-wide analysis.
Uryu K, Nishimura R, Kataoka K, Sato Y, Nakazawa A, Suzuki H, Yoshida K, Seki M, Hiwatari M, Isobe T, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Koh K, Hanada R, Oka A, Hayashi Y, Ohira M, Kamijo T, Nagase H, Takimoto T, Tajiri T, Nakagawara A, Ogawa S, Takita J. Uryu K, et al. Oncotarget. 2017 Nov 18;8(64):107513-107529. doi: 10.18632/oncotarget.22495. eCollection 2017 Dec 8. Oncotarget. 2017. PMID: 29296183 Free PMC article.
References
- Nature. 1987 Dec 10-16;330(6148):578-81 - PubMed
- Prog Hematol. 1986;14:229-56 - PubMed
- Nature. 1988 Jan 21;331(6153):273-7 - PubMed
- Proc Natl Acad Sci U S A. 1987 Dec;84(24):9059-63 - PubMed
- Nature. 1986 Aug 14-20;322(6080):644-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical